Kapitalo Investimentos Ltda Invests $331,000 in Nu Skin Enterprises, Inc. $NUS

Key Points

• Kapitalo Investimentos Ltda has acquired 41,372 shares of Nu Skin Enterprises, valued at approximately $331,000, representing ownership of 0.08% of the company.
• Recent analyst ratings for Nu Skin Enterprises have shown upgrades, with Wall Street Zen elevating its rating from "buy" to "strong-buy" and an overall consensus price target of $6.88.
• Nu Skin Enterprises reported a quarterly EPS of $0.43, exceeding consensus estimates, alongside a net margin of 6.20% and revenue of $386.14 million.

Kapitalo Investimentos Ltda bought a new position in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 41,372 shares of the company's stock, valued at approximately $331,000. Kapitalo Investimentos Ltda owned 0.08% of Nu Skin Enterprises as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Two Sigma Investments LP increased its holdings in Nu Skin Enterprises by 24.2% during the 4th quarter. Two Sigma Investments LP now owns 700,500 shares of the company's stock worth $4,826,000 after acquiring an additional 136,624 shares during the period. Man Group plc raised its position in shares of Nu Skin Enterprises by 125.5% in the fourth quarter. Man Group plc now owns 102,836 shares of the company's stock worth $709,000 after buying an additional 57,235 shares in the last quarter. New York State Teachers Retirement System bought a new stake in Nu Skin Enterprises during the first quarter valued at $33,000. Wealth Enhancement Advisory Services LLC purchased a new position in Nu Skin Enterprises during the first quarter worth about $118,000. Finally, Hsbc Holdings PLC bought a new position in Nu Skin Enterprises in the 1st quarter worth about $619,000. 82.84% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Nu Skin Enterprises

In other Nu Skin Enterprises news, Director Daniel W. Campbell sold 23,391 shares of the company's stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $12.10, for a total transaction of $283,031.10. Following the completion of the transaction, the director owned 53,375 shares of the company's stock, valued at $645,837.50. This represents a 30.47% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Laura Nathanson sold 6,489 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $12.22, for a total value of $79,295.58. Following the completion of the sale, the director owned 33,149 shares of the company's stock, valued at approximately $405,080.78. This trade represents a 16.37% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 58,926 shares of company stock worth $711,364. 2.00% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on NUS shares. Wall Street Zen upgraded shares of Nu Skin Enterprises from a "buy" rating to a "strong-buy" rating in a research report on Saturday. Zacks Research raised shares of Nu Skin Enterprises to a "hold" rating in a report on Tuesday, August 12th. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $6.88.

Nu Skin Enterprises Trading Up 6.5%

Shares of NUS traded up $0.79 during mid-day trading on Monday, reaching $12.88. The company's stock had a trading volume of 1,392,842 shares, compared to its average volume of 489,778. Nu Skin Enterprises, Inc. has a 52 week low of $5.32 and a 52 week high of $13.17. The stock has a market cap of $637.56 million, a PE ratio of 6.41 and a beta of 0.92. The company's fifty day moving average price is $10.61 and its two-hundred day moving average price is $8.48. The company has a current ratio of 2.01, a quick ratio of 1.38 and a debt-to-equity ratio of 0.27.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.18. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. The business had revenue of $386.14 million during the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. On average, analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 10th. Shareholders of record on Friday, August 29th were issued a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend was Friday, August 29th. Nu Skin Enterprises's dividend payout ratio (DPR) is 11.94%.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.